相关实验视频

Updated: Jul 24, 2025

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

针对非小细胞肺癌的免疫检查点药物的研究取得了进展

Yue Shen¹, Juan Chen^1,2, Xiang-Ping Li^1,2

¹Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.

Journal of drug targeting

|July 7, 2023

概括

免疫检查点抑制剂显著改善非小细胞肺癌 (NSCLC) 患者的生存率. 像LAG-3和TIM-3这样的新兴目标为个性化NSCLC治疗提供了新的途径,解决了当前的挑战.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

非小细胞肺癌 (NSCLC) 是全球领先的恶性瘤,占肺癌病例的85%.
免疫疗法已经彻底改变了NSCLC患者的预后.
了解免疫检查点对于推进NSCLC治疗至关重要.

研究的目的:

审查临床应用和对NSCLC免疫检查点抑制剂和激动剂的最新研究.
为目前和新兴的NSCLC免疫疗法提供临床指导.
突出NSCLC免疫疗法的挑战和未来方向.

主要方法:

临床应用和研究的综合文献综述.
对常用和新兴免疫检查点抑制剂和激动剂的分析.
评估NSCLC治疗中的疗效,安全性和耐药性机制.

主要成果:

PD-1/PD-L1和CTLA-4抑制剂是已建立的NSCLC治疗方法,改善了生存率和生活质量.
挑战包括瘤复杂性,变异性,耐药性和不良事件.
新的检查点 (LAG-3,TIM-3,OX-40,ICOS) 提供了新的治疗目标.

结论:

免疫检查点抑制剂在NSCLC治疗中至关重要.
新兴的抑制剂和激动剂提供了有前途的个性化治疗机会.
对疗效和安全性的进一步研究将提高NSCLC患者的治疗结果.

关键词:

国际投资机构 (ICI) 是国际投资机构 (ICI) 的一个组成部分.在NSCLCLC中,我们可以看到.在PD-1/PD-L1中.免疫检查点药物药物免疫检查点免疫疗法免疫疗法

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.